190 related articles for article (PubMed ID: 34525262)
1. CFTR gene mutation spectrum among 735 Iranian patients with cystic fibrosis: A comprehensive systematic review.
Alibakhshi R; Mohammadi A; Khamooshian S; Kazeminia M; Moradi K
Pediatr Pulmonol; 2021 Dec; 56(12):3644-3656. PubMed ID: 34525262
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
[TBL] [Abstract][Full Text] [Related]
3. Novel CFTR Mutations in Two Iranian Families with Severe Cystic Fibrosis.
Mohseni M; Razzaghmanesh M; Parsi Mehr E; Zare H; Beheshtian M; Najmabadi H
Iran Biomed J; 2016 Sep; 20(4):201-6. PubMed ID: 27017198
[TBL] [Abstract][Full Text] [Related]
4. A haplotype framework for cystic fibrosis mutations in Iran.
Elahi E; Khodadad A; Kupershmidt I; Ghasemi F; Alinasab B; Naghizadeh R; Eason RG; Amini M; Esmaili M; Esmaeili Dooki MR; Sanati MH; Davis RW; Ronaghi M; Thorstenson YR
J Mol Diagn; 2006 Feb; 8(1):119-27. PubMed ID: 16436643
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of CFTR gene mutations in Iranian Azeri Turkish patients with cystic fibrosis.
Bonyadi M; Omrani O; Rafeey M; Bilan N
Genet Test Mol Biomarkers; 2011; 15(1-2):89-92. PubMed ID: 21198395
[TBL] [Abstract][Full Text] [Related]
6. Identification and
Hosseini Nami A; Kabiri M; Zafarghandi Motlagh F; Shirzadeh T; Bagherian H; Zeinali R; Karimi A; Zeinali S
Ther Adv Respir Dis; 2024; 18():17534666241253990. PubMed ID: 38904297
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous spectrum of CFTR gene mutations in Korean patients with cystic fibrosis.
Jung H; Ki CS; Koh WJ; Ahn KM; Lee SI; Kim JH; Ko JS; Seo JK; Cha SI; Lee ES; Kim JW
Korean J Lab Med; 2011 Jul; 31(3):219-24. PubMed ID: 21779199
[TBL] [Abstract][Full Text] [Related]
8. Mutation and new polymorphisms insight in introns 11 to 14a of CFTR gene of northern Iranian cystic fibrosis patients.
Esmaeili Dooki MR; Tabaripour R; Rahimi R; Akhavan-Niaki H
Gene; 2015 Jun; 564(2):193-6. PubMed ID: 25824381
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients.
Alibakhshi R; Zamani M
Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):3-8. PubMed ID: 17242497
[TBL] [Abstract][Full Text] [Related]
10. Reporting Two Novel Mutations in Two Iranian Families with Cystic Fibrosis, Molecular and Bioinformatic Analysis.
Hosseini Nami A; Kabiri M; Zeinali S
Iran Biomed J; 2022 Nov; 26(5):398-405. PubMed ID: 35468710
[TBL] [Abstract][Full Text] [Related]
11. Poly thymidine polymorphism and cystic fibrosis in a non-Caucasian population.
Tabaripour R; Niaki HA; Douki MR; Bazzaz JT; Larijani B; Yaghmaei P
Dis Markers; 2012; 32(4):241-6. PubMed ID: 22430190
[TBL] [Abstract][Full Text] [Related]
12. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
Southern KW; Patel S; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
[TBL] [Abstract][Full Text] [Related]
13. The CF-modifying gene EHF promotes p.Phe508del-CFTR residual function by altering protein glycosylation and trafficking in epithelial cells.
Stanke F; van Barneveld A; Hedtfeld S; Wölfl S; Becker T; Tümmler B
Eur J Hum Genet; 2014 May; 22(5):660-6. PubMed ID: 24105369
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of CFTR mutations in Chechen cystic fibrosis patients: high frequency of c.1545_1546delTA (p.Tyr515X; 1677delTA) and c.274G>A (p.Glu92Lys, E92K) mutations in North Caucasus.
Petrova NV; Kashirskaya NY; Saydaeva DK; Polyakov AV; Adyan TA; Simonova OI; Gorinova YV; Kondratyeva EI; Sherman VD; Novoselova OG; Vasilyeva TA; Marakhonov AV; Macek M; Ginter EK; Zinchenko RA
BMC Med Genet; 2019 Mar; 20(1):44. PubMed ID: 30898088
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous spectrum of mutations in CFTR gene from Indian patients with congenital absence of the vas deferens and their association with cystic fibrosis genetic modifiers.
Sharma H; Mavuduru RS; Singh SK; Prasad R
Mol Hum Reprod; 2014 Sep; 20(9):827-35. PubMed ID: 24958810
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of Cystic Fibrosis Conductance Regulator Gene Mutations Reported in Pakistani Descent Cystic Fibrosis Patients.
Majid H; Khan AH; Hashmi SB; Moatter T; Nasir A
J Coll Physicians Surg Pak; 2022 Aug; 32(8):1042-1046. PubMed ID: 35932130
[TBL] [Abstract][Full Text] [Related]
17. Exploring the diversity of
Rafique H; Safdar A; Ghani MU; Akbar A; Awan FI; Naeem Z; Amar A; Awan MF; Wajahat Ullah S; Shaikh RS
J Asthma; 2024 Jun; 61(6):511-519. PubMed ID: 38153325
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of cystic fibrosis transmembrane conductance regulator mutations.
Mickle JE; Cutting GR
Clin Chest Med; 1998 Sep; 19(3):443-58, v. PubMed ID: 9759548
[TBL] [Abstract][Full Text] [Related]
19. The Inhibition of the Membrane-Bound Transcription Factor Site-1 Protease (MBTP1) Alleviates the p.Phe508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Defects in Cystic Fibrosis Cells.
Santinelli R; Benz N; Guellec J; Quinquis F; Kocas E; Thomas J; Montier T; Ka C; Luczka-Majérus E; Sage E; Férec C; Coraux C; Trouvé P
Cells; 2024 Jan; 13(2):. PubMed ID: 38247876
[TBL] [Abstract][Full Text] [Related]
20. Lumacaftor/ivacaftor combination for cystic fibrosis patients homozygous for Phe508del-CFTR.
Zhang W; Zhang X; Zhang YH; Strokes DC; Naren AP
Drugs Today (Barc); 2016 Apr; 52(4):229-37. PubMed ID: 27252987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
